Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.917 EUR | -1.40% | -2.73% | -14.89% |
Apr. 30 | Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale | MT |
Apr. 29 | ApotekstjÄNst Sverige Ab cancelled the acquisition of Svensk Dos AB. | CI |
Sales 2024 * | 1.55B 1.69B | Sales 2025 * | 1.59B 1.73B | Capitalization | 175M 190M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 16M 17.4M | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | 5.3M 5.76M | Net cash position 2025 * | 23.36M 25.4M | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
10.3
x | Employees | 800 |
Yield 2024 * |
8.6% | Yield 2025 * |
9.32% | Free-Float | 70.11% |
Latest transcript on Oriola Oyj
1 day | -2.21% | ||
1 week | -0.96% | ||
Current month | +3.91% | ||
1 month | -13.08% | ||
3 months | -11.09% | ||
6 months | -7.92% | ||
Current year | -14.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 11-12-31 | |
Director of Finance/CFO | 54 | 22-11-30 | |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 22-12-31 | |
Director/Board Member | 55 | 22-12-31 | |
Harri Pärssinen
BRD | Director/Board Member | 61 | 19-01-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +4.06% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.926 | -0.43% | 83 358 |
24-05-15 | 0.93 | -2.21% | 172,292 |
24-05-14 | 0.951 | -1.25% | 149,777 |
24-05-13 | 0.963 | +1.16% | 109,810 |
24-05-10 | 0.952 | +1.38% | 143,180 |
Delayed Quote Nasdaq Helsinki, May 16, 2024 at 03:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.52% | 190M | |
+19.13% | 71.69B | |
-3.66% | 23.65B | |
+8.80% | 9.01B | |
+11.24% | 8.64B | |
-18.91% | 8.15B | |
+16.00% | 5.33B | |
+17.83% | 4.35B | |
-2.11% | 4.1B | |
-1.72% | 3.94B |
- Stock Market
- Equities
- OKDBV Stock